<?xml version="1.0" encoding="UTF-8"?>
<bibdataset xsi:schemaLocation="http://www.elsevier.com/xml/ani/ani http://www.elsevier.com/xml/ani/ani512.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns="http://www.elsevier.com/xml/ani/ani">
<item>
<ait:process-info>
<ait:date-delivered year="2016" month="06" day="15"/>
<ait:date-sort year="2015" month="01" day="01"/>
<ait:status type="core" state="new" stage="S300"/>
</ait:process-info>
<bibrecord>
<item-info>
<copyright type="Elsevier">Copyright 2016 Elsevier B.V., All rights reserved.</copyright>
<itemidlist>
<ce:doi>10.3233/978-1-61499-564-7-975</ce:doi>
<itemid idtype="PUI">10403635</itemid>
<itemid idtype="CAR-ID">643592588</itemid>
<itemid idtype="NURSNG">2016002332</itemid>
<itemid idtype="SNEMB">2016001390</itemid>
</itemidlist>
<history>
<date-created timestamp="BST 05:16:11" year="2016" month="01" day="04"/>
</history>
<dbcollection>NURSNG</dbcollection>
<dbcollection>SNEMB</dbcollection>
</item-info>
<head>
<citation-info>
<citation-type code="cp"/>
<citation-language xml:lang="eng"/>
<abstract-language xml:lang="eng"/>
<author-keywords>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
</author-keywords>
</citation-info>
<citation-title>
<titletext xml:lang="eng" original="y">the</titletext>
</citation-title>
<author-group>
<author seq="1" type="auth">
<ce:initials>M.</ce:initials>
<ce:indexed-name>Nishikitani M.</ce:indexed-name>
<ce:surname>Nishikitani</ce:surname>
<ce:given-name>Mariko</ce:given-name>
<ce:e-address>makorin@med.kyushu-u.ac.jp</ce:e-address>
</author>
<author seq="5" type="auth">
<ce:initials>A.</ce:initials>
<ce:indexed-name>Ahmed A.</ce:indexed-name>
<ce:surname>Ahmed</ce:surname>
<ce:given-name>Ashir</ce:given-name>
</author>
<author seq="6" type="auth">
<ce:initials>N.</ce:initials>
<ce:indexed-name>Nakashima N.</ce:indexed-name>
<ce:surname>Nakashima</ce:surname>
<ce:given-name>Naoki</ce:given-name>
</author>
<affiliation country="jpn">
<organization>Institute of Decision Science for A Sustainable Society</organization>
<organization>Kyushu University</organization>
<address-part>3-1-1 Maidashi</address-part>
<city>Fukuoka</city>
<postal-code>812-8582</postal-code>
</affiliation>
</author-group>
<author-group>
<author seq="2" type="auth">
<ce:initials>Y.</ce:initials>
<ce:indexed-name>Nohara Y.</ce:indexed-name>
<ce:surname>Nohara</ce:surname>
<ce:given-name>Yasunobu</ce:given-name>
</author>
<author seq="6" type="auth">
<ce:initials>N.</ce:initials>
<ce:indexed-name>Nakashima N.</ce:indexed-name>
<ce:surname>Nakashima</ce:surname>
<ce:given-name>Naoki</ce:given-name>
</author>
<affiliation country="jpn">
<organization>Medical Information Center</organization>
<organization>Kyushu University Hospital</organization>
<city>Fukuoka</city>
</affiliation>
</author-group>
<author-group>
<author seq="3" type="auth">
<ce:initials>P.</ce:initials>
<ce:indexed-name>Ghosh P.</ce:indexed-name>
<ce:surname>Ghosh</ce:surname>
<ce:given-name>Partha</ce:given-name>
</author>
<author seq="4" type="auth">
<ce:initials>R.</ce:initials>
<ce:indexed-name>Islam Maruf R.</ce:indexed-name>
<ce:surname>Islam Maruf</ce:surname>
<ce:given-name>Rafiqul</ce:given-name>
</author>
<affiliation country="bgd">
<organization>Grameen Communications</organization>
<city>Dhaka</city>
</affiliation>
</author-group>
<author-group>
<author seq="5" type="auth">
<ce:initials>A.</ce:initials>
<ce:indexed-name>Ahmed A.</ce:indexed-name>
<ce:surname>Ahmed</ce:surname>
<ce:given-name>Ashir</ce:given-name>
</author>
<affiliation country="jpn">
<organization>Graduate School of Information Science and Electrical Engineering</organization>
<organization>Kyushu University</organization>
<city>Fukuoka</city>
</affiliation>
</author-group>
<correspondence>
<person>
<ce:initials>M.</ce:initials>
<ce:indexed-name>Nishikitani M.</ce:indexed-name>
<ce:surname>Nishikitani</ce:surname>
<ce:given-name>Mariko</ce:given-name>
</person>
<affiliation country="jpn">
<organization>Institute of Decision Science for A Sustainable Society</organization>
<organization>Kyushu University</organization>
<address-part>3-1-1 Maidashi</address-part>
<city>Fukuoka</city>
<postal-code>812-8582</postal-code>
</affiliation>
<ce:e-address>makorin@med.kyushu-u.ac.jp</ce:e-address>
</correspondence>
<abstracts>
<abstract original="y">
<publishercopyright>Â© 2015 IMIA and IOS Press.</publishercopyright>
<ce:para>Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication. The acute toxicity of organophosphorus (OP) compounds in mammals is due to their irreversible inhibition of acetylcholinesterase (AChE) in the nervous system, which leads to increased synaptic acetylcholine levels. The protective actions of intravenously (i.v.) administered pyridostigmine, physostigmine, eptastigmine, and an organophosphate hydrolase, phosphotriesterase, in acute sarin intoxication were studied in mice. The acute intragastric (i.g.) toxicity (LD50) of sarin with and without the pretreatments was tested by the up-and-down method. The mice received pyridostigmine (0.06 mg/kg body weight), physostigmine (0.09 mg/kg body weight), the physostigmine derivative eptastigmine (0.90 mg/kg body weight) or phosphotriesterase (104 U/g, 10.7 microg/g body weight) 10 min prior to the i.g. administration of sarin. Physostigmine was also administered with phosphotriesterase. Phosphotriesterase was the most effective antidote in sarin intoxication. The LD50 value for sarin increased 3.4-fold in mice receiving phosphotriesterase. Physostigmine was the most effective carbamate in sarin exposure. The protective ratios of physostigmine and pyridostigmine were 1.5- and 1.2-1.3-fold, respectively. Eptastigmine did not give any protection against sarin toxicity. Both the phosphotriesterase and physostigmine treatments protected the brain AChE activities measured 24 h after sarin exposure. In phosphotriesterase and physostigmine-treated mice, a 4- and 2-fold higher sarin dose, respectively, was needed to cause a 50% inhibition of brain AChE activity. Moreover, the combination of phosphotriesterase-physostigmine increased the LD50 value for sarin 4.3-fold. The animals pretreated with phosphotriesterase-ephysostigmine tolerated four times the lethal dose in control animals, furthermore their survival time was 2-3 h in comparison to 20 min in controls. In conclusion, phosphotriesterase and physostigmine were the most effective treatments against sarin intoxication. However, eptastigmine did not provide any protection against sarin toxicity.</ce:para>
</abstract>
</abstracts>
<source type="k" country="nld">
<sourcetitle>Studies in Health Technology and Informatics</sourcetitle>
<sourcetitle-abbrev>Stud. Health Technol. Informatics</sourcetitle-abbrev>
<translated-sourcetitle xml:lang="eng">Studies in Health Technology and Informatics</translated-sourcetitle>
<issuetitle>MEDINFO 2015: eHealth-Enabled Health - Proceedings of the 15th World Congress on Health and Biomedical Informatics</issuetitle>
<issn type="electronic">18798365</issn>
<issn type="print">09269630</issn>
<isbn type="electronic" length="13" level="volume">9781614995630</isbn>
<volisspag>
<voliss volume="216"/>
<pagerange first="975"/>
</volisspag>
<publicationyear first="2015"/>
<publicationdate>
<year>2015</year>
</publicationdate>
<website>
<ce:e-address>http://www.iospress.nl/bookserie/studies-in-health-technology-and-informatics/</ce:e-address>
</website>
<contributor-group>
<contributor seq="1" role="edit">
<ce:initials>A.</ce:initials>
<ce:indexed-name>Georgiou A.</ce:indexed-name>
<ce:surname>Georgiou</ce:surname>
<ce:given-name>Andrew</ce:given-name>
</contributor>
</contributor-group>
<contributor-group>
<contributor seq="1" role="edit">
<ce:initials>I.N.</ce:initials>
<ce:indexed-name>Sarkar I.N.</ce:indexed-name>
<ce:degrees>Dr.</ce:degrees>
<ce:surname>Sarkar</ce:surname>
<ce:given-name>Indra Neil</ce:given-name>
</contributor>
</contributor-group>
<contributor-group>
<contributor seq="1" role="edit">
<ce:initials>P.M.</ce:initials>
<ce:indexed-name>de Azevedo Marques P.M.</ce:indexed-name>
<ce:surname>de Azevedo Marques</ce:surname>
<ce:given-name>Paulo Mazzoncini</ce:given-name>
</contributor>
</contributor-group>
<publisher>
<publishername>IOS Press</publishername>
<affiliation country="nld">
<address-part>Nieuwe Hemweg 6B</address-part>
<city>Amsterdam</city>
<postal-code>1013 BG</postal-code>
</affiliation>
</publisher>
<additional-srcinfo>
<conferenceinfo>
<confevent>
<confname>15th World Congress on Health and Biomedical Informatics, MEDINFO 2015</confname>
<confnumber>15</confnumber>
<conftheme>eHealth-Enabled Health</conftheme>
<confseriestitle>World Congress on Health and Biomedical Informatics</confseriestitle>
<conflocation country="bra">
<city>Sao Paulo</city>
</conflocation>
<confdate>
<startdate year="2015" month="08" day="19"/>
<enddate year="2015" month="08" day="23"/>
</confdate>
<confcode>116956</confcode>
<confsponsors complete="n">
<confsponsor></confsponsor>
</confsponsors>
</confevent>
</conferenceinfo>
</additional-srcinfo>
</source>
<enhancement>
<classificationgroup>
<classifications type="ASJC">
<classification>2204</classification>
<classification>2718</classification>
<classification>3605</classification>
</classifications>
</classificationgroup>
</enhancement>
</head>
<tail>
<bibliography refcount="1"/>
</tail>
</bibrecord>
</item>
</bibdataset>
